Eye on innovators.

For more than two decades, ClinImmune Cell & Gene Therapy at Fitzsimons Innovation Community has been blazing trails in the field of organ and stem cell transplantation. The organization’s unique approach to leveraging its leadership position contributes to Colorado’s momentum in this growing space.

Fitzsimons Innovation Community Wins CBSA Building Momentum Award Fitzsimons Innovation Community is the inaugural recipient of the Colorado BioScience Association’s new Award: Building Momentum. This award recognizes investments an honoree is making to advance Colorado’s life sciences community and better position the entire ecosystem for growth. Expansion and growth are just part of the story here. It’s about supporting people, fostering connections, and creating an environment that helps spark discoveries. April Giles, Fitzsimons Innovation Community Vice President of Business, answers key questions about the momentum building at Fitzsimons Innovation Community. Q: Tell us more about the momentum building at Fitzsimons...

  Elevation Diagnostics Supports People and the Planet with Precision Testing Elevation Diagnostics addresses the growing demand for fast, accurate diagnostic testing in our community. With its flagship location at Fitzsimons Innovation Community, Elevation Diagnostics offers clinical and environmental testing in its state-of-the-art labs. The company offers a two-fold approach to public health: helping doctors heal patients and helping companies keep the earth free of toxins with accurate, timely results. Whether working with campuses and businesses to provide students and employees with a different health care option or working directly with the patient, Elevation Diagnostics strives to empower people to...

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcase groundbreaking research and innovations in the region. Learn more about the 2022 presenting companies from our Community who share a passion for taking their research to the next level to improve care, cure diseases, and save lives.

InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in emerging advanced treatments like cell therapies, gene therapies, and the new generation of vaccines.

Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a botanical medicine approach, Invenux aims to break down barriers to save and change the lives of sickle cell disease patients.